Appili Therapeutics Inc. (APLI.TO) TSX

0.03

+0.005(+25.00%)

Updated at January 14 09:30AM

Currency In CAD

Valuation

Market Cap4.24M
Enterprise Value15.31M
P/E Ratio-0.96
PEG Ratio0.09
Price/Sales Ratio12.15
Price/Book Ratio-0.16
Enterprise/Revenue71.61
Enterprise/EBITDA-16.23

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-12.69
Operating Margin-8.48

Management Effectiveness

Return On Assets-3.36
Return On Equity0.18

Income Statement

Revenue100,443
Revenue/Share0
Gross Profit100,443
EBITDA360,566
Net Income-2.62M
Diluted EPS-0.02

Balance Sheet

Total Cash348,679
Total Cash/Share0
Total Debt12.22M
Total Debt/Equity-0.78
Current Ratio0.05
Book Value Per Share-0.13

Price History

52-Week Change-50
52-Week High0.05
52-Week Low0.01
Moving Average 50 Days0.02
Moving Average 200 Days0.02

Statistics

Average Volume60,855
Shares Outstanding121.27M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A